United States · FDA National Drug Code directory
Efavirenz
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 65862-105_a02dd4c8-6159-48b0-a79c-c362f1f4daf9
- Product NDC
- 65862-105
- Form
- CAPSULE
- Composition / generic term
- Efavirenz
- Labeler
- Aurobindo Pharma Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20171215
- Source listing expiry
- 20261231
Source-listed ingredients
- EFAVIRENZ — 100 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 3 BLISTER PACK in 1 CARTON (65862-105-10) / 10 CAPSULE in 1 BLISTER PACK · 65862-105-10
- 30 CAPSULE in 1 BOTTLE (65862-105-30) · 65862-105-30
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →